Radiochemotherapie bei fortgeschrittenem Zervixkarzinom – neue Daten vom European Society for Medical Oncology(ESMO)-Kongress 2023
摘要
Combined chemoradiotherapy has been the standard nonsurgical treatment for locally advanced cervical cancer since the 1990s. Guidelines also recommend chemoradiotherapy in the definitive or adjuvant setting for patients with inoperable tumors or risk factors. At the 2023 congress of the European Society for Medical Oncology (ESMO), new studies were presented that expand the current treatment standards and will lead to long-term changes in the treatment landscape.